Literature DB >> 21417824

High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia.

Zsófia Balogh1, Lilla Reiniger, Hajnalka Rajnai, Judit Csomor, Agota Szepesi, Anikó Balogh, Linda Deák, Eva Gagyi, Csaba Bödör, András Matolcsy.   

Abstract

In lymph nodes, chronic lymphocytic leukemia (CLL) cells (prolymphocytes and paraimmunoblasts) form proliferation centers (PCs), which are also known as pseudofollicles. To reveal whether PCs play a role in the accumulation of genetic alterations in CLL, we compared deletion at 11q22.3, 13q14.3, and 17p13.1 loci and trisomy 12 by the fluorescence in situ hybridization (FISH) technique in PCs versus surrounding small lymphocytes (SLs) in 12 formalin-fixed paraffin-embedded (FFPE) lymph nodes. The FFPE sections were stained with methylene blue and PCs were marked by laser beam. Subsequent FISH analysis was performed, relocalizing the previously defined regions. Loss of 11q was detected in five cases, loss of 13q in two cases, loss of 17p in two cases, and trisomy 12 in one case. In seven cases PCs contained a significantly higher ratio of cells with genetic alterations compared with the surrounding SLs. Our results show that CLL cells with genetic alterations tend to accumulate in PCs. The clonal expansion of the cell population carrying genetic alterations within PCs may contribute to CLL progression.

Entities:  

Mesh:

Year:  2011        PMID: 21417824     DOI: 10.3109/10428194.2011.555889

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  5 in total

1.  Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression.

Authors:  Joel F Gradowski; Rachel L Sargent; Fiona E Craig; Kathleen Cieply; Kim Fuhrer; Carol Sherer; Steven H Swerdlow
Journal:  Am J Clin Pathol       Date:  2012-07       Impact factor: 2.493

2.  Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.

Authors:  Ilaria Del Giudice; Marilisa Marinelli; Jiguang Wang; Silvia Bonina; Monica Messina; Sabina Chiaretti; Caterina Ilari; Luciana Cafforio; Sara Raponi; Francesca Romana Mauro; Valeria Di Maio; Maria Stefania De Propris; Mauro Nanni; Carmela Ciardullo; Davide Rossi; Gianluca Gaidano; Anna Guarini; Raul Rabadan; Robin Foà
Journal:  Br J Haematol       Date:  2015-11-24       Impact factor: 6.998

Review 3.  Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.

Authors:  Yair Herishanu; Ben-Zion Katz; Andrew Lipsky; Adrian Wiestner
Journal:  Hematol Oncol Clin North Am       Date:  2013-04       Impact factor: 3.722

4.  The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.

Authors:  David Oscier; Monica Else; Estella Matutes; Ricardo Morilla; Jonathan C Strefford; Daniel Catovsky
Journal:  Br J Haematol       Date:  2016-05-06       Impact factor: 6.998

5.  Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy.

Authors:  Marika Porrazzo; Emanuele Nicolai; Mara Riminucci; Candida Vitale; Marta Coscia; Lorenzo De Paoli; Angela Rago; Giulia Buscicchio; Giacomo Maestrini; Silvio Ligia; Alessio Di Prima; Alessandro Corsi; Roberto Caronna; Gianluca Gaidano; Francesca Romana Mauro
Journal:  Cancers (Basel)       Date:  2020-07-03       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.